In vitro up-regulation of HLA-G using dexamethasone and hydrocortisone in first-trimester trophoblast cells of women experiencing recurrent miscarriage

Tissue Antigens

Volumn 80, Issue 2, 2012, Pages 126-135

  Akhter, A ^a,b   Faridi, R M ^a   Das, V ^b   Pandey, A ^b   Naik, S ^a   Agrawal, S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cytotrophoblast; Dexamethasone; Human leukocyte antigen G; Hydrocortisone; Recurrent miscarriage

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; HYDROCORTISONE;

3' UNTRANSLATED REGION; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUS ABORTION; UPREGULATION; WESTERN BLOTTING;

EID: 85027928073     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01884.x     Document Type: Article

References (48)

1. Rai R, Regan L. Recurrent miscarriage. Lancet 2006: 368: 601-11.
2. McMaster MT, Librach CL, Zhou Y et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995: 154: 3771-8.
3. King A, Loke YW. On the nature and function of human uterine granular lymphocytes. Immunol Today 1991: 12: 432.
4. Rajagopalan S, Bryceson YT, Kuppusamy SP et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006: 4: 9.
5. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997: 94: 11520-5.
6. Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigen 2004: 64: 215-25.
7. Shiroishi M, Tsumoto K, Amano K et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 2003: 100: 8856-61.
8. Carosella ED, Favier B, Rouas-Freiss N, Moreau P, LeMaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008: 111: 4862-70.
9. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999: 189: 1093-100.
10. Ashkar AA, Di Santo JP, Croy BA. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000: 192: 259-70.
11. Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 1998: 187: 217-23.
12. Paul P, Cabestre FA, Ibrahim EC et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000: 61: 1138-49.
13. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000: 355: 2138.
14. Rouas-Freiss N, Bruel S, Menier C, Marcou C, Moreau P, Carosella ED. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis. Int J Cancer 2005: 117: 114-22.
15. Morales PJ, Pace JL, Platt JS, Langat DK, Hunt JS. Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007: 122: 179-88.
16. Alegre E, Diaz-Lagares A, Lemaoult J, Lopez-Moratalla N, Carosella ED, Gonzalez A. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. Hum Immunol 2007: 68: 661-7.
17. Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000: 183: 682-8.
18. Hackmon R, Hallak M, Krup M et al. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn Ther 2004: 19: 404-9.
19. Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005: 193: 204-8.
20. Rizzo R, Stignani M, Amoudruz P et al. Allergic women have reduced sHLA-G plasma levels at delivery. Am J Reprod Immunol 2009: 61: 368-76.
21. Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H. Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol 2003: 23: 307-14.
22. Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006: 11: 309-16.
23. Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 2007: 57: 277-86.
24. Pfeiffer KA, Rebmann V, Passler M et al. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum Immunol 2000: 61: 559-64.
25. Yie SM, Xiao R, Librach CL. Progesterone regulates HLA-G gene expression through a novel progesterone response element. Hum Reprod 2006: 21: 2538-44.
26. Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol 1996: 156: 4224-31.
27. Moreau P, Adrian-Cabestre F, Menier C et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999: 11: 803-11.
28. Moreau P, Faure O, Lefebvre S et al. Glucocorticoid hormones upregulates levels of HLA-G Transcripts in Trophoblasts. Transplant proc 2001: 33: 2277-80.
29. Peng B, Zhang L, Xing AY, Hu M, Liu SY. The expression of human leukocyte antigen G and E on human first trimester placenta and its relationship with recurrent spontaneous abortion. Sichuan Da Xue Xue Bao Yi Xue Ban 2008: 39: 976-9.
30. Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placenta tissue are decreased in preeclampsia. Fertil Steril 2004: 83: 30-6.
31. Akhter A, Das V, Naik S, Faridi RM, Pandey A, Agrawal S. Up-regulation of HLA-G in JEG-3 cells by dexamethasone and hydrocortisone. Arch Gynecol Obstet 2012: 285: 7-14.
32. Ober C, Billstrand C, Kuldanek S, Tan Z. The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells. Hum Reprod 2006: 21: 1743-8.
33. Nicolae D, Cox NJ, Lester LA et al. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 2005: 76: 349-57.
34. Auboeuf D, Honig A, Berget SM, O'Malley BW. Co-ordinate regulation of transcription and splicing by steroid receptor coregulators. Science 2002: 298: 416-9.
35. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003: 64: 1005-10.
36. Hviid TV, Rizzo R, Melchiorri L, Stignani M, Baricordi OR. Polymorphism in the 5′ upstream regulatory and 3′ untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol 2006: 67: 53-62.
37. Faridi RM, Das V, Tripthi G, Talwar S, Parveen F, Agrawal S. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum Reprod 2009: 24: 1758-64.
38. Kliman HJ, Nestler JE, Sarmasi E, Sanger JM, Strauss JF. Purification characterization and in vitro differentiation of cytotrophoblast from human term placenta. Endocrinology 1986: 118: 1567.
39. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979: 76: 4350-4.
40. Szekeres-Bartho J, Szekeres J. Immunosuppression by Progesterone in Pregnancy. Boca Raton: CRC Press, 1992.
41. Kovats S, Main E, Librach C, Stubblebine M, Fisher S, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990: 248: 220-3.
42. Mallet V, Blaschitz A, Crisa L et al. HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol 1999: 11: 889-98.
43. Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003: 64: 1039-44.
44. Cirulli V, Zalatan J, McMaster M et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006: 55: 1214-22.
45. Menier C, Rabreau M, Challier JC, Le Discorde M, Carosella ED, Rouas-Freiss N. Erythroblasts molecule in heart-graft acceptance. Lancet 2000: 355: 2138.
46. Agaugue S, Carosella ED, Rouas-Freiss N. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance favoring Th2 vs Th1/Th17. Blood 2011: 117: 7021-31.
47. Ivanova E, Mourdjeva M, Kyurkchiev D et al. HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. Am J Reprod Immunol 2009: 62: 25-33.
48. Moreau P, Moullot G, Rousseau P, Marcou C, Dausset J, Carosella D. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci USA 2002: 3: 1191-6.